Indaptus Therapeutics is trading at $1.21 (7.6% down) in after-hours trading, reversing part of a sharp intraday rebound.
- The stock climbed approximately 10% during regular hours on August 3, 2026, in a technical rebound following a multi-day selloff.
- No fresh company-specific headlines or regulatory updates were reported to account for the price movement.
- The after-hours weakness likely reflects profit-taking and continued volatility following the short-term bounce.